Uribel

— THERAPEUTIC CATEGORIES —
  • Urinary tract discomfort

Uribel Generic Name & Formulations

General Description

Methenamine 118mg, sodium phosphate monobasic 40.8mg, phenyl salicylate 36mg, methylene blue 10mg, hyoscyamine sulfate 0.12mg; caps.

Pharmacological Class

Urinary tract analgesic/antispasmodic/antiseptic.

How Supplied

Caps—100

Uribel Indications

Indications

Treatment of symptoms of irritative voiding. Relief of local symptoms due to lower UTIs or diagnostic procedures.

Uribel Dosage and Administration

Adult

1 cap 4 times daily.

Children

≤6yrs: not recommended. >6yrs: individualize dose.

Uribel Contraindications

Contraindications

Cardiac disease. GI or GU obstruction. Glaucoma. Myasthenia gravis.

Uribel Boxed Warnings

Not Applicable

Uribel Warnings/Precautions

Warnings/Precautions

Discontinue if rapid pulse, dizziness, or blurred vision occurs. Gastric ulcers. Maintain acid urine and adequate hydration. Elderly. Pregnancy (Cat.C). Nursing mothers.

Uribel Pharmacokinetics

See Literature

Uribel Interactions

Interactions

Allow at least 2 hours after ketoconazole. May be potentiated by antimuscarinics, MAOIs. Reduced intestinal motility with antimyasthenics. Increased risk of severe constipation with opioids. May be antagonized by thiazide diuretics, urinary alkalinizers. Separate dosing of antacids, antidiarrheals by 1 hour. May reduce absorption of other drugs. Sulfonamides precipitate with formaldehyde in urine; avoid concomitant use.

Uribel Adverse Reactions

Adverse Reactions

Rapid pulse, flushing, blurred vision, dizziness, shortness of breath, acute urinary retention, difficult micturition, dry mouth, nausea, vomiting, discolored urine/feces.

Uribel Clinical Trials

See Literature

Uribel Note

Not Applicable

Uribel Patient Counseling

See Literature

Images